Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 470 word(s) 470 2020-12-15 08:12:17

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Liu, R. TGFB2 Gene. Encyclopedia. Available online: (accessed on 24 June 2024).
Liu R. TGFB2 Gene. Encyclopedia. Available at: Accessed June 24, 2024.
Liu, Rui. "TGFB2 Gene" Encyclopedia, (accessed June 24, 2024).
Liu, R. (2020, December 25). TGFB2 Gene. In Encyclopedia.
Liu, Rui. "TGFB2 Gene." Encyclopedia. Web. 25 December, 2020.
TGFB2 Gene

transforming growth factor beta 2


1. Normal Function

The TGFB2 gene provides instructions for producing a protein called transforming growth factor beta-2 (TGFβ-2). This protein is found throughout the body and is required for development before birth and throughout life. To carry out its functions, TGFβ-2 attaches (binds) to receptor proteins on the surface of cells. This binding triggers the transmission of signals within cells, controlling various cellular activities. As part of a signaling pathway called the TGF-β pathway, the TGFβ-2 protein helps control the growth and division (proliferation) of cells, the process by which cells mature to carry out specific functions (differentiation), cell movement (motility), and controlled cell death (apoptosis). Because the TGFβ-2 protein keeps cells from growing and dividing too rapidly or in an uncontrolled way, it can suppress the formation of tumors.

The TGFβ-2 protein plays a role in the formation of blood vessels, the regulation of muscle tissue and body fat development, wound healing, and immune system function. TGFβ-2 is especially abundant in tissues that make up the skeleton, where it helps regulate bone growth, and in the intricate lattice that forms in the spaces between cells (the extracellular matrix).

2. Health Conditions Related to Genetic Changes

2.1. Loeys-Dietz syndrome

At least 20 mutations in the TGFB2 gene have been found to cause Loeys-Dietz syndrome type IV. This disorder affects connective tissue, which gives structure and support to blood vessels, the skeleton, and many other parts of the body. Loeys-Dietz syndrome type IV is characterized by blood vessel abnormalities, heart defects, and skeletal deformities. The TGFB2 gene mutations that cause this condition lead to the production of a TGFβ-2 protein with little or no function. As a result, the protein cannot bind to its receptors. Although the TGFβ-2 protein and its receptors are not bound, TGF-β pathway signaling occurs at an even greater intensity than normal. Researchers speculate that the activity of other proteins in this signaling pathway is increased to compensate for the reduction in TGFβ-2 activity; however, the exact mechanism responsible for the increase in signaling is unclear. The overactive signaling pathway disrupts development of connective tissue and various body systems and leads to the signs and symptoms of Loeys-Dietz syndrome type IV.

A few mutations have been found that delete the entire TGFB2 gene and some nearby genetic material. People with these deletions often have the features of Loeys-Dietz syndrome as well as features not usually associated with the condition, such as intellectual disability and movement problems. Researchers are working to determine which genes are missing as a result of these deletions and how their loss contributes to these additional signs and symptoms.

3. Other Names for This Gene

  • BSC-1 cell growth inhibitor
  • cetermin
  • G-TSF
  • glioblastoma-derived T-cell suppressor factor
  • polyergin
  • TGF-beta2
  • transforming growth factor beta-2
  • transforming growth factor, beta 2


  1. Heldin CH, Landström M, Moustakas A. Mechanism of TGF-beta signaling to growtharrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol.2009 Apr;21(2):166-76. doi: 10.1016/
  2. Heldin CH, Moustakas A. Role of Smads in TGFβ signaling. Cell Tissue Res. 2012Jan;347(1):21-36. doi: 10.1007/s00441-011-1190-x.
  3. Lindsay ME, Schepers D, Bolar NA, Doyle JJ, Gallo E, Fert-Bober J, Kempers MJ,Fishman EK, Chen Y, Myers L, Bjeda D, Oswald G, Elias AF, Levy HP, Anderlid BM,Yang MH, Bongers EM, Timmermans J, Braverman AC, Canham N, Mortier GR, BrunnerHG, Byers PH, Van Eyk J, Van Laer L, Dietz HC, Loeys BL. Loss-of-functionmutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm.Nat Genet. 2012 Jul 8;44(8):922-7. doi: 10.1038/ng.2349.
  4. Ritelli M, Chiarelli N, Dordoni C, Quinzani S, Venturini M, Maroldi R,Calzavara-Pinton P, Colombi M. Further delineation of Loeys-Dietz syndrome type 4in a family with mild vascular involvement and a TGFB2 splicing mutation. BMC MedGenet. 2014 Aug 28;15:91. doi: 10.1186/s12881-014-0091-8.
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 619
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 25 Dec 2020
Video Production Service